JP Patent

JP7454520B2 — 光学活性なアザビシクロ環誘導体からなる医薬

Assigned to Sumitomo Pharma Co Ltd · Expires 2024-03-22 · 2y expired

What this patent protects

Patent listed against revumenib-citrate.

Drugs covered by this patent

revumenib-citrate (REVUMENIB CITRATE)

Patent Metadata

Patent number: JP7454520B2
Jurisdiction: JP
Classification: —
Expires: 2024-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.